NYSE:MSDL • US61774A1034
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MORGAN STANLEY DIRECT LENDIN (MSDL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-03-02 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2026-03-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-07 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-11-26 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-11-10 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-11-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-10 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2025-10-06 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-16 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-08 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-03 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-13 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-07-29 | JP Morgan | Maintains | Neutral -> Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 230.593M 92.46% | 367.738M 59.47% | 416.075M 13.14% | 405.65M -2.51% | 372.1M -8.27% | 361.19M -2.93% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 128.344M 75.79% | 199.58M 55.50% | 222.672M 11.57% | 213.18M -4.26% | 208.08M -2.39% | N/A | |
| Operating Margin | 55.66% | 54.27% | 53.52% | 52.55% | 55.92% | N/A | |
| EPS YoY % growth | N/A | N/A | 2.49 -8.30% | 2.06 -14.06% | 1.87 -12.57% | 1.82 -2.74% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.49 -6.69% | 0.47 -5.87% | 0.47 -6.74% | 0.46 -25.73% | 0.45 -7.51% | 0.45 -4.64% | 0.45 -3.75% | 0.45 -3.27% |
| Revenue Q2Q % growth | 96.367M -5.02% | 94.309M 2.76% | 92.865M -6.88% | 91.555M -12.24% | 91.754M -4.79% | 91.754M -2.71% | 91.754M -1.20% | 91.754M 0.22% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
13 analysts have analysed MSDL and the average price target is 17.89 USD. This implies a price increase of 22.26% is expected in the next year compared to the current price of 14.63.
MORGAN STANLEY DIRECT LENDIN (MSDL) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of MORGAN STANLEY DIRECT LENDIN (MSDL) is 0.49 USD and the consensus revenue estimate is 96.37M USD.
The consensus rating for MORGAN STANLEY DIRECT LENDIN (MSDL) is 73.8462 / 100 . This indicates that analysts generally have a positive outlook on the stock.